COLLABORATIVE DATA SERVICES SHARED RESOURCE (CDSSR) The mission of Collaborative Data Services Shared Resource (CDSSR) at the Fred Hutch/University of Washington Cancer Consortium is to provide strategic service in the design, oversight, and implementation of scientific studies by Consortium faculty members. CDSSR is comprised of two units, Programming and Interviewing & Data Operations which are managed by unit managers with expertise in these areas, and is directed by Dr. Catherine Duggan, with guidance from a 14-member faculty oversight committee, which meets biannually. CDSSR services support Consortium goals by (1) providing access to programming services and expertise; (2) providing access to a research call center and to a highly trained team of research interviewers; (3) providing data management solutions, encompassing data entry, remote, secure data capture, and secure data storage; (4) developing novel, tailored approaches to individual projects? needs including workflow design, customized programming, and application of new technologies; (5) educating and training Consortium faculty and staff on data capture, programming, data science, and interviewing techniques; and (6) providing infrastructure support to maintain programmatic functions ? for example, design of biospecimen repositories, call center management, and database maintenance. CDSSR supports multiple studies that are recruiting participants, capturing data, surveying study participants, designing and managing biospecimen repositories, and implementing funded research studies. Since 2015, CDSSR has supported 232 projects from 66 Consortium members across all 8 Consortium research programs; increased its client base by an average of 63% over 4 years (FY 2015-FY 2018); supported the publication of over 60 manuscripts; held over 40 training classes in electronic data capture technologies and scientific programming; and increased cost-effectiveness and efficiency of multiple studies. Priority is given to Consortium faculty with peer-reviewed projects and junior faculty seeking peer-reviewed funding. The resource continues to expand upon its technical, collaborative, and administrative expertise, by providing access to current technologies adapted for research use and expanding its client base.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-45
Application #
9853657
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Linden, Hannah M; Peterson, Lanell M; Fowler, Amy M (2018) Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 13:415-422
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005
Molina, Yamile; Briant, Katherine J; Sanchez, Janeth I et al. (2018) Knowledge and social engagement change in intention to be screened for colorectal cancer. Ethn Health 23:461-479
Winters, Brian R; Vakar-Lopez, Funda; Brown, Lisha et al. (2018) Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy. Urol Oncol 36:342.e7-342.e14
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288
Baker, K Scott; Syrjala, Karen L (2018) Long-term complications in adolescent and young adult leukemia survivors. Hematology Am Soc Hematol Educ Program 2018:146-153
Miller, Chris P; Tsuchida, Connor; Zheng, Ying et al. (2018) A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis. Neoplasia 20:610-620
Paulson, K G; Voillet, V; McAfee, M S et al. (2018) Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun 9:3868
Puronen, Camille E; Cassaday, Ryan D; Stevenson, Philip A et al. (2018) Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma. Biol Blood Marrow Transplant 24:2211-2215

Showing the most recent 10 out of 1267 publications